Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma
<p>Abstract</p> <p>Background</p> <p>Immunohistochemical detection of prostate specific antigen (PSA) is widely used to identify metastatic prostatic adenocarcinoma. However, PSA may not be expressed in some poorly differentiated prostatic carcinomas and its immunoreact...
Saved in:
Main Authors: | Parwani Anil V (Author), Dhir Rajiv (Author), Yin Ming (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2007-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic utility of immunohistochemical marker prostein for evaluation of primary and metastatic prostatic carcinomas
by: Gowri Garudadri, et al.
Published: (2020) -
Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
by: Xin LIU, et al.
Published: (2015) -
Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015) -
Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015) -
Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma
by: Parwani Anil V, et al.
Published: (2011)